PTEN and familial pancreatic carcinoma: Silencing of miR-21, which targets PTEN, was shown to alleviate ROS-induced activation, migration, and glycolysis of PSCs and to inhibit pancreatic cancer cells simultaneously (Yan et al., 2018).